Literature DB >> 23510075

Treatment options for disorders of arousal: a case series.

Hrayr Attarian1, Lirong Zhu.   

Abstract

BACKGROUND: Non-rapid-eye-movement parasomnias or disorders of arousal (DOA) are more prevalent in children, but they do occur in adults. There are no practice parameters published for treatment of DOAs.
METHODS: After obtaining institutional review board approval, an electronic search was conducted for ICD9 codes related to DOAs in our clinic databases. The resulting charts were reviewed by the authors for accuracy, and 103 out of 232 were included in the final analysis.
RESULTS: Sleepwalking is the most common DOA presentation. Treatment with low-dose clonazepam has a response rate of 73.7%. Cognitive behavioral therapy (CBT) for insomnia, sertraline, clomipramine and temazepam may also be effective alternatives.
CONCLUSION: DOAs respond to benzodiazepines, antidepressants and CBT. Large, randomized trials are needed to further assess these therapeutic alternatives.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23510075     DOI: 10.3109/00207454.2013.783579

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  5 in total

1.  Sleepwalking.

Authors:  Valérie Cochen De Cock
Journal:  Curr Treat Options Neurol       Date:  2016-02       Impact factor: 3.598

2.  ATS Core Curriculum 2016: Part I. Adult Sleep Medicine.

Authors:  Jay S Balachandran; Carey C Thomson; Dezmond B Sumter; Anita V Shelgikar; Philippe Lachapelle; Sushmita Pamidi; Michael Fall; Chitra Lal; Ridhwan Y Baba; Neomi Shah; Barry G Fields; Kathleen Sarmiento; Matthew P Butler; Steven A Shea; Janelle V Baptiste; Katherine M Sharkey; Tisha Wang
Journal:  Ann Am Thorac Soc       Date:  2016-04

Review 3.  Therapeutic Symptomatic Strategies in the Parasomnias.

Authors:  Raffaele Manni; Gianpaolo Toscano; Michele Terzaghi
Journal:  Curr Treat Options Neurol       Date:  2018-06-05       Impact factor: 3.598

4.  Integrative behavioral treatment for NREM parasomnias: a case series.

Authors:  Jennifer M Mundt; Kelly G Baron
Journal:  J Clin Sleep Med       Date:  2021-06-01       Impact factor: 4.324

Review 5.  The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice.

Authors:  Giuseppe Loddo; Giovanna Calandra-Buonaura; Luisa Sambati; Giulia Giannini; Annagrazia Cecere; Pietro Cortelli; Federica Provini
Journal:  Front Neurol       Date:  2017-02-16       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.